Literature DB >> 5664156

The use of regional heparinization for perfusion of the kidney in situ.

F Carswell, R Hainsworth, J R Ledsome.   

Abstract

Mesh:

Substances:

Year:  1968        PMID: 5664156      PMCID: PMC1570225          DOI: 10.1111/j.1476-5381.1968.tb00998.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN: 0366-0826


× No keyword cloud information.
  8 in total

1.  Acute effect of changes in renal arterial pressure and sympathetic blockade on kidney function.

Authors:  J B LANGSTON; A C GUYTON; W J GILLESPIE
Journal:  Am J Physiol       Date:  1959-09

2.  Studies in regional heparinization. II. Artificial-kidney hemodialysis without systemic heparinization; preliminary report of a method using simultaneous infusion of heparin and protamine.

Authors:  L A GORDON; H A PERKINS; V RICHARDS; J M RUKES; E R SIMON
Journal:  N Engl J Med       Date:  1956-12-06       Impact factor: 91.245

3.  Studies in regional heparinization. I. The use of simultaneous neutralization with protamine; preliminary studies.

Authors:  L A GORDON; H A PERKINS; V RICHARDS
Journal:  N Engl J Med       Date:  1956-11-29       Impact factor: 91.245

4.  Renal vascular and systemic arterial pressure responses to nervous and chemical stimulation of the kidney.

Authors:  I H PAGE; J W MCCUBBIN
Journal:  Am J Physiol       Date:  1953-06

5.  Effect of pulse pressure and mean arterial pressure modification on renal hemodynamics and electrolyte and water excretion.

Authors:  E E SELKURT
Journal:  Circulation       Date:  1951-10       Impact factor: 29.690

6.  THE DETERMINATION OF SODIUM IN BODY FLUIDS BY THE GLASS ELECTRODE.

Authors:  E W Moore; D W Wilson
Journal:  J Clin Invest       Date:  1963-03       Impact factor: 14.808

7.  THE USE OF HEPARIN IN THROMBOSIS.

Authors:  G D Murray; C H Best
Journal:  Ann Surg       Date:  1938-08       Impact factor: 12.969

8.  Heterologous liver perfusion in treatment of hepatic failure.

Authors:  B Eiseman; D S Liem; F Raffucci
Journal:  Ann Surg       Date:  1965-09       Impact factor: 12.969

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.